David H. Harpole

Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

Gary M. Strauss, James E. Herndon, Michael A. Maddaus et al. · Journal of Clinical Oncology · 2008 · 990 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database

Subroto Paul, Nasser K. Altorki, Shubin Sheng et al. · Journal of Thoracic and Cardiovascular Surgery · 2010 · 798 citations · Full text

Medicine, Surgery, General Surgery +7

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

John V. Heymach, David H. Harpole, Tetsuya Mitsudomi et al. · New England Journal of Medicine · 2023 · 682 citations · Full text

Medicine, Oncology, Perioperative Medicine +17

Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial

Mark S. Allen, Gail Darling, Taine Pechet et al. · The Annals of Thoracic Surgery · 2006 · 675 citations

Medicine, Oncology, Surgery +14

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

Laura R. Saunders, Alexander J. Bankovich, Wade Anderson et al. · Science Translational Medicine · 2015 · 578 citations

Medicine, Oncology, Pharmacology +17